We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » AstraZeneca’s Purchase of Alexion Gets EU Approval
AstraZeneca’s Purchase of Alexion Gets EU Approval
AstraZeneca’s planned acquisition of Alexion Pharmaceuticals, a prominent developer of drugs for rare diseases, has received a green light from the European Commission.